Remodelling and Inhibition of Energy Metabolism during the Mitochondrial Life Cycle of Trypanosomatid Parasites
Description of the granted funding
Trypanosomatid parasites cause lethal diseases, such as visceral leishmaniasis and Chagas disease, infecting ~7 million people worldwide. Available drugs for these diseases suffer from severe toxic side effects and emergence of drug resistance. The mitochondrion, the powerhouse of the cell, harbours an energy-converting protein machinery called complex III, which is essential for parasite survival and a confirmed drug target, but its three-dimensional structure is unknown. Using tomographic methods at the electron microscopy unit of the University of Helsinki, we will determine how the parasite achieves a tight packing of complex III molecules inside its powerhouse. Using high-resolution electron microscopy, we will determine the molecular structure of complex III bound to anti-trypanosomatid inhibitors to reveal how they block the protein complex. This project will expand our understanding of a fundamental cell biological process in human parasites and inform future drug development.
Show moreStarting year
2025
End year
2029
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy projects
Decision maker
Scientific Council for Biosciences, Health and the Environment
16.06.2025
16.06.2025
Other information
Funding decision number
371050
Fields of science
Biochemistry, cell and molecular biology
Research fields
Biokemia, biofysiikka
Identified topics
molecular biology, biochemistry